Results 191 to 200 of about 27,883 (236)
Some of the next articles are maybe not open access.

Implantable Cardioverter–Defibrillators

New England Journal of Medicine, 2003
Most people do not survive out-of-hospital cardiac arrest, and those who do may have substantial long-term cognitive and motor impairment. ICDs may avert such events. This review discusses the mechanisms of ICDs, clinical studies of their effectiveness, and management issues.
openaire   +2 more sources

Automatic Implantable Cardioverter-Defibrillators

Emergency Medicine Clinics of North America, 1994
The AICD represents a major technologic advance for patients with life-threatening ventricular tachyarrhythmias in whom drug or surgical therapy is unsuccessful. A significant reduction in mortality in these patients is seen with AICD use. As the device becomes more widely available and more centers in the country become adept in its implantation and ...
D W, Munter, W A, DeLacey
openaire   +2 more sources

The Subcutaneous Implantable Cardioverter Defibrillator

Cardiology in Review, 2016
The subcutaneous implantable cardioverter defibrillator (S-ICD) is a subcutaneous alternative to conventional transvenous ICD (TV-ICD) systems, which have previously been shown to treat life-threatening ventricular tachyarrhythmias in cardiac disease patients.
Daniel, Mangels, William H, Frishman
openaire   +2 more sources

Implantable Cardioverter‐Defibrillators in Children

Pacing and Clinical Electrophysiology, 2008
Implantable cardioverter‐defibrillators (ICD) in adults have shown to be safe and effective for both primary and secondary prevention of sudden cardiac death (SCD). In children and patients with congenital heart disease prospective trials to evaluate the safety and efficacy of these devices are still lacking.
openaire   +2 more sources

A Prophylactic Implantable Cardioverter-Defibrillator?

The American Journal of Cardiology, 1996
Antiarrhythmic drugs have systematically failed to improve--or have even worsened prognosis--when given prophylactically to "high-risk" patients without previous spontaneous sustained ventricular arrhythmias. In patients who have had > or = 1 episode(s) of near sudden cardiac death or sustained ventricular arrhythmias, randomized studies against ...
P, Brugada, F, Wellens, E, Andries
openaire   +2 more sources

Implantable cardioverter-defibrillators in children

Archives of Disease in Childhood, 2014
Implantable cardioverter-defibrillators (ICD) have become an integral component in the management of children with life-threatening cardiac arrhythmias complicating a variety of different inherited and congenital cardiovascular conditions. Implantation often requires novel approaches and configurations to overcome the size and anatomic limitations ...
Elizabeth S, DeWitt, Dominic J, Abrams
openaire   +2 more sources

Advances in implantable cardioverter defibrillators

Current Opinion in Cardiology, 2002
Implantable cardioverter defibrillators (ICDs) have become an important therapeutic modality for patients who have had a cardiac arrest or are at risk for life-threatening ventricular arrhythmias. Clinical trials have confirmed the role of the ICD for patients with sustained ventricular arrhythmias and have expanded the indications to include patients ...
Craig, Swygman   +4 more
openaire   +2 more sources

Use of Implantable cardioverter-defibrillators

Future Cardiology, 2010
The implantable cardioverter-defibrillator (ICD) is the most effective treatment for patients with life-threatening ventricular tachycardia or ventricular fibrillation not due to reversible causes. The American College of Cardiology/American Heart Association class I and IIa indications for an ICD are discussed.
openaire   +2 more sources

The patient with an implantable cardioverter defibrillator

Journal of PeriAnesthesia Nursing, 2003
Electrophysiologic technology developed over the past 20 years has improved the life expectancy of patients who have survived sudden cardiac death events. Use of an implantable cardioverter defibrillator (ICD) continues to increase as more indications for the device are researched.
openaire   +2 more sources

Implantable Cardioverter Defibrillator:

Journal of Cardiovascular Electrophysiology, 1993
Implantable Cardioverter Defibrillator. The Ventritex® Cadence® Model V‐100 Tiered Therapy Defibrillator is a third generation antitachyarrhythmia device currently completing clinical trials in the United States. The implantable pulse generator is capable of high energy detibrillation, low energy cardioversion, as well as antitachycardia and ...
E S, Fain, R A, Winkle
openaire   +2 more sources

Home - About - Disclaimer - Privacy